ONESOURCE
Invest with MTF
Invest Now
Invest in OneSource Specialty Pharma with 1.92X leverage
Performance
- Low
- ₹1,172
- High
- ₹1,255
- 52 Week Low
- ₹1,057
- 52 Week High
- ₹2,248
- Open Price₹1,247
- Previous Close₹1,174
- Volume394,572
- 50 DMA₹1,582.13
- 100 DMA₹1,667.45
- 200 DMA₹1,693.57
Investment Returns
- Over 1 Month -34.56%
- Over 3 Month -36.49%
- Over 6 Month -36.53%
- Over 1 Year -21.62%
Smart Investing Starts Here Start SIP with OneSource Specialty Pharma for Steady Growth!
OneSource Specialty Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 671.5
- PEG Ratio
- 6
- Market Cap Cr
- 13,498
- P/B Ratio
- 2.3
- Average True Range
- 91.48
- EPS
- 2.67
- Dividend Yield
- 0
- MACD Signal
- -108.68
- RSI
- 23.54
- MFI
- 12.35
OneSource Specialty Pharma Financials
OneSource Specialty Pharma Technicals
EMA & SMA
Current Price
₹1,177.60
+
3.3
(0.28%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹1,427.33
- 50 Day
- ₹1,582.13
- 100 Day
- ₹1,667.45
- 200 Day
- ₹1,693.57
Resistance and Support
1201.43
- R3 1,312.97
- R2 1,283.73
- R1 1,230.67
- S1 1,148.37
- S2 1,119.13
- S3 1,066.07
OneSource Specialty Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-23 | Quarterly Results | |
| 2025-11-11 | Quarterly Results | |
| 2025-08-04 | Quarterly Results | |
| 2025-05-05 | Audited Results | |
| 2025-01-29 | Quarterly Results |
OneSource Specialty Pharma F&O
About OneSource Specialty Pharma
- NSE Symbol
- ONESOURCE
- BSE Symbol
- 544292
- Managing Director & CEO
- Mr. Neeraj Sharma
- ISIN
- INE013P01021
Similar Stocks to OneSource Specialty Pharma
OneSource Specialty Pharma FAQs
OneSource Specialty Pharma share price is ₹1,177 As on 03 February, 2026 | 20:17
The Market Cap of OneSource Specialty Pharma is ₹13497.8 Cr As on 03 February, 2026 | 20:17
The P/E ratio of OneSource Specialty Pharma is 671.5 As on 03 February, 2026 | 20:17
The PB ratio of OneSource Specialty Pharma is 2.3 As on 03 February, 2026 | 20:17
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.